17-49043518-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_006546.4(IGF2BP1):c.1168G>A(p.Val390Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000953 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006546.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGF2BP1 | NM_006546.4 | c.1168G>A | p.Val390Ile | missense_variant | 10/15 | ENST00000290341.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGF2BP1 | ENST00000290341.8 | c.1168G>A | p.Val390Ile | missense_variant | 10/15 | 1 | NM_006546.4 | P1 | |
IGF2BP1 | ENST00000431824.2 | c.751G>A | p.Val251Ile | missense_variant | 8/13 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000418 AC: 105AN: 251374Hom.: 0 AF XY: 0.000383 AC XY: 52AN XY: 135862
GnomAD4 exome AF: 0.00100 AC: 1468AN: 1461826Hom.: 0 Cov.: 33 AF XY: 0.000924 AC XY: 672AN XY: 727222
GnomAD4 genome AF: 0.000466 AC: 71AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.1168G>A (p.V390I) alteration is located in exon 10 (coding exon 10) of the IGF2BP1 gene. This alteration results from a G to A substitution at nucleotide position 1168, causing the valine (V) at amino acid position 390 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at